Abstract
WIN 55212-2 is an endocannabinoids analogue that has been reported to have anti-inflammatory and anti-fibrosis effects on different models. In this study, we investigated the protective effects of WIN 55212-2 on paraquat (PQ)-induced poison on mice especially on lung injury. Mice were administrated with different dose of PQ and thereafter treated with 0.2 mg/kg or 1 mg/kg WIN 55212-2. The survival of mice was recorded during 4 weeks of observation. Twenty-eight days after PQ treatment, the cell population and inflammatory factors IL-6, IL-10, and TNF-α were measured in bronchoalveolar lavage fluid (BALF). Pulmonary fibrosis was evaluated by Masson staining. Our results showed that WIN 55212-2 treatment reduced PQ-induced mortality of mice in a dose dependent manner. It decreased the number of inflammation-associated cells, as well as the level of pro-inflammatory factors in BALF (P < 0.05). WIN 55212-2 increased M2 cells in BALF (P < 0.05), improved the lung histology, reduced fibrosis formation, and decreased TGF-β, α-SMA and PDGFRa expression. The protective effects of WIN 55212-2 on PQ-induced lung injury and fibrosis were associated with an increase inM2 cells and increased expressions of IL-10, CD163, and CD206, suggesting that polarization of M2 macrophages may be involved in WIN 55212-2 protective effects on PQ-induced lung injury.
Keywords: IL-10, M2 macrophage, WIN 55212–2, lung fibrosis, macrophage polarization, paraquat
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
References
-
- Elenga, N., C. Merlin, R. Le Guern, R. Kom-Tchameni, Y.M. Ducrot, M. Pradier, B. Ntab, K.A. Dinh-Van, M. Sobesky, D. Mathieu, et al. 2018. Clinical features and prognosis of paraquat poisoning in French Guiana: A review of 62 cases. Medicine (Baltimore) 97 (15): e9621. – DOI
-
- Smith, L.L. 1982. Young Scientists Award lecture 1981: the identification of an accumulation system for diamines and polyamines into the lung and its relevance to paraquat toxicity. Archives of toxicology Supplement = Archiv fur Toxikologie Supplement 5:1–14.
-
- Balistreri, E., E. Garcia-Gonzalez, E. Selvi, A. Akhmetshina, K. Palumbo, S. Lorenzini, R. Maggio, M. Lucattelli, M. Galeazzi, and J.W. Distler. 2011. The cannabinoid WIN 55, 212–2 abrogates dermal fibrosis in scleroderma bleomycin model. Annals of the rheumatic diseases 70 (4): 695–699. – PubMed – DOI